Molecular determinants of prostate cancer metastasis.

作者: Kiera Rycaj , Dean G. Tang

DOI: 10.18632/ONCOTARGET.21085

关键词:

摘要: // Kiera Rycaj 1 and Dean G. Tang 1, 2 Department of Pharmacology Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA Stem Cell Research Center for Translational Medicine, East Hospital, Tongji University School Shanghai 200120, China Correspondence to: Rycaj, email: Kiera.Rycaj@Roswellpark.org Tang, Dean.Tang@Roswellpark.org Keywords: metastasis, prostate cancer, cancer stem cells, molecular mechanisms Received: July 15, 2017      Accepted: August 31, Published: September 19, 2017 ABSTRACT Metastatic remains largely incurable fatal. The general course from the initiation primary tumor formation progression to is a multistep process wherein cells at each step must display specific phenotypic features. Distinctive capabilities required growth form foundation, sometimes may remain critical, subsequent metastases. These features easily malleable during acquisition additional unique essential metastatic such as dissemination distant tissues interact with foreign microenvironments. Thus, phenotype culmination multiple genetic epigenetic alterations selection favorable traits under pressure ever-changing Although our understanding programs that drive metastasis are incomplete, increasing evidence suggests successful colonization relies on (CSCs) tumor-regenerating capacity adaptive survival in organs. In past 2-3 years, myriad novel regulators determinants have been reported, this Perspective, we comprehensively review body literature summarize recent findings regarding cell autonomous critical metastasis.

参考文章(132)
Nazanin Ruppender, Sandy Larson, Bryce Lakely, Lori Kollath, Lisha Brown, Ilsa Coleman, Roger Coleman, Holly Nguyen, Peter S. Nelson, Eva Corey, Linda A. Snyder, Robert L. Vessella, Colm Morrissey, Hung-Ming Lam, Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy. PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0130565
C Coarfa, W Fiskus, V K Eedunuri, K Rajapakshe, C Foley, S A Chew, S S Shah, C Geng, J Shou, J S Mohamed, B W O'Malley, N Mitsiades, Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer. Oncogene. ,vol. 35, pp. 2345- 2356 ,(2016) , 10.1038/ONC.2015.295
Ahmad Al-Azayzih, Payaningal R. Somanath, Fei Gao, Discrete Functions Of GSK3α And GSK3β Isoforms In Prostate Tumor Growth And Micrometastasis The FASEB Journal. ,vol. 29, ,(2015)
Marcus Ruscetti, Bill Quach, Eman L. Dadashian, David J. Mulholland, Hong Wu, Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis Cancer Research. ,vol. 75, pp. 2749- 2759 ,(2015) , 10.1158/0008-5472.CAN-14-3476
Joshua D. Brown-Clay, Deepika N. Shenoy, Olga Timofeeva, Bhaskar V. Kallakury, Asit K. Nandi, Partha P. Banerjee, PBK/TOPK enhances aggressive phenotype in prostate cancer via β-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion Oncotarget. ,vol. 6, pp. 15594- 15609 ,(2015) , 10.18632/ONCOTARGET.3709
Nelma Pertega‐Gomes, Sergio Felisbino, Charlie E Massie, Jose R Vizcaino, Ricardo Coelho, Chiranjeevi Sandi, Susana Simoes‐Sousa, Sarah Jurmeister, Antonio Ramos‐Montoya, Mohammad Asim, Maxine Tran, Elsa Oliveira, Alexandre Lobo da Cunha, Valdemar Maximo, Fatima Baltazar, David E Neal, Lee GD Fryer, A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy The Journal of Pathology. ,vol. 236, pp. 517- 530 ,(2015) , 10.1002/PATH.4547
Huimin Sun, Lei Zhang, Changhong Shi, Peizhen Hu, Wei Yan, Zhe Wang, Qiuhong Duan, Fan Lu, Lipeng Qin, Tao Lu, Juanjuan Xiao, Yingmei Wang, Feng Zhu, Chen Shao, TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer Oncotarget. ,vol. 6, pp. 12392- 12404 ,(2015) , 10.18632/ONCOTARGET.3630
Shibao Li, Yingyu Ma, Chongwei Xie, Zhiyuan Wu, Zhihua Kang, Zujun Fang, Bing Su, Ming Guan, EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression Oncotarget. ,vol. 6, pp. 22587- 22597 ,(2015) , 10.18632/ONCOTARGET.4088
Wei-Yu Chen, Shih-Yang Liu, Yung-Sheng Chang, Juan Juan Yin, Hsiu-lien Yeh, Tarek H. Mouhieddine, Ola Hadadeh, Wassim Abou-Kheir, Yen-Nien Liu, MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer Oncotarget. ,vol. 6, pp. 441- 457 ,(2015) , 10.18632/ONCOTARGET.2690
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro, Juan-Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C Pritchard, Gerhardt Attard, Himisha Beltran, Wassim Abida, Robert K Bradley, Jake Vinson, Xuhong Cao, Pankaj Vats, Lakshmi P Kunju, Maha Hussain, Felix Y Feng, Scott A Tomlins, Kathleen A Cooney, David C Smith, Christine Brennan, Javed Siddiqui, Rohit Mehra, Yu Chen, Dana E Rathkopf, Michael J Morris, Stephen B Solomon, Jeremy C Durack, Victor E Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T Lis, Michaela Bowden, Stephen P Balk, Glenn Gaviola, Carrie Sougnez, Manaswi Gupta, Y Yu Evan, Elahe A Mostaghel, Heather H Cheng, Hyojeong Mulcahy, Lawrence D True, Stephen R Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquin Mateo, Raquel Perez-Lopez, Francesca Demichelis, Brian D Robinson, Marc Schiffman, David M Nanus, Scott T Tagawa, Alexandros Sigaras, Kenneth W Eng, Olivier Elemento, Andrea Sboner, Elisabeth I Heath, Howard I Scher, Kenneth J Pienta, Philip Kantoff, Johann S De Bono, Mark A Rubin, Peter S Nelson, Levi A Garraway, Charles L Sawyers, Arul M Chinnaiyan, None, Integrative clinical genomics of advanced prostate cancer Cell. ,vol. 161, pp. 1215- 1228 ,(2015) , 10.1016/J.CELL.2015.05.001